Eli Lilly
Company
In the last 30 days MAP recorded 17 pages from 2 sources whose headlines mention Eli Lilly (17 MAP records, 23 observations in all). The newest was observed Oct 9, 2026 13:37 UTC. 3 items in the feeds MAP monitors now mention it.
Pages are matched to Eli Lilly by its name in the headline, using an automated word match. A match does not mean the page is about Eli Lilly in any particular way. MAP does not verify, score, rate or fact-check what the pages say, and headlines and links belong to the publishers.
Latest developments
Items in the news feeds MAP monitors whose headline mentions Eli Lilly, newest first. They link to the publisher.
healthline.com · date not provided
FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation
MAP records
Records of pages MAP ingested from the feeds it monitors, newest first. Open one to see what MAP observed for that page and its observation history.
statnews.com · observed
Lilly's Jaypirca approved as first-line CLL therapy
statnews.com · observed
Lilly bypasses Australian pharmacies with DTC model
statnews.com · observed
Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
statnews.com · observed
Lilly wins approval for once-weekly insulin shot
cnbc.com · observed
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
7 more in the last 30 days are not listed here.
Sources
statnews.com (12), cnbc.com (5).
The domains of the matched pages from the last 30 days, with the number of pages in brackets. Feed items with no publication date are not counted. A count is not a quality measure: MAP does not rate sources. Sources with a MAP page are linked.
Compiled Oct 9, 2026 19:35 UTC from MAP’s ledger and the feeds it monitors; covers the last 30 days. Headline words matched: eli lilly, lilly. Phrases ignored: lilly wachowski, lilly singh, lilly pulitzer.